Cao Yang, Wei Wei, Zhang Nan, Yu Qing, Xu Wen-Bin, Yu Wen-Jun, Chen Guo-Qiang, Wu Ying-Li, Yan Hua
Department of Hematology, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
Department of Hematology, Xinhua Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai, China.
BMC Cancer. 2015 Apr 10;15:248. doi: 10.1186/s12885-015-1219-8.
Retinoic acid receptor alpha (RARα) plays an essential role in the regulation of many biological processes, such as hematopoietic cell differentiation, while abnormal RARα function contributes to the pathogenesis of certain diseases including cancers, especially acute promyelocytic leukemia (APL). Recently, oridonin, a natural diterpenoid isolated from Rabdosia rubescens, was demonstrated to regulate RARα by increasing its protein level. However, the underlying molecular mechanism for this action has not been fully elucidated.
In the APL cell line, NB4, the effect of oridonin on RARα protein was analyzed by western blot and real-time quantitative RT-PCR analyses. Flow cytometry was performed to detect intracellular levels of reactive oxygen species (ROS). The association between nuclear factor-kappa B (NF-κB) signaling and the effect of oridonin was assessed using specific inhibitors, shRNA gene knockdown, and immunofluorescence assays. In addition, primary leukemia cells were treated with oridonin and analyzed by western blot in this study.
RARα possesses transcriptional activity in the presence of its ligand, all-trans retinoic acid (ATRA). Oridonin remarkably stabilized the RARα protein, which retained transcriptional activity. Oridonin also moderately increased intracellular ROS levels, while pretreatment with the ROS scavenger, N-acetyl-l-cysteine (NAC), dramatically abrogated RARα stabilization by oridonin. More intriguingly, direct exposure to low concentrations of H2O2 also increased RARα protein but not mRNA levels, suggesting a role for ROS in oridonin stabilization of RARα protein. Further investigations showed that NAC antagonized oridonin-induced activation of NF-κB signaling, while the NF-κB signaling inhibitor, Bay 11-7082, effectively blocked the oridonin increase in RARα protein levels. In line with this, over-expression of IκΒα (A32/36), a super-repressor form of IκΒα, or NF-κB-p65 knockdown inhibited oridonin or H2O2-induced RARα stability. Finally, tumor necrosis factor alpha (TNFα), a classical activator of NF-κB signaling, modulated the stability of RARα protein.
Oridonin stabilizes RARα protein by increasing cellular ROS levels, which causes activation of the NF-κB signaling pathway.
维甲酸受体α(RARα)在许多生物学过程的调节中发挥着重要作用,如造血细胞分化,而RARα功能异常会导致包括癌症在内的某些疾病的发病机制,尤其是急性早幼粒细胞白血病(APL)。最近,从冬凌草中分离出的一种天然二萜类化合物冬凌草甲素,被证明可通过增加RARα蛋白水平来调节RARα。然而,这种作用的潜在分子机制尚未完全阐明。
在APL细胞系NB4中,通过蛋白质免疫印迹法和实时定量逆转录-聚合酶链反应分析冬凌草甲素对RARα蛋白的影响。采用流式细胞术检测细胞内活性氧(ROS)水平。使用特异性抑制剂、短发夹RNA(shRNA)基因敲低和免疫荧光分析评估核因子κB(NF-κB)信号传导与冬凌草甲素作用之间的关联。此外,本研究用冬凌草甲素处理原代白血病细胞并通过蛋白质免疫印迹法进行分析。
在其配体全反式维甲酸(ATRA)存在的情况下,RARα具有转录活性。冬凌草甲素显著稳定了具有转录活性的RARα蛋白。冬凌草甲素还适度增加了细胞内ROS水平,而用ROS清除剂N-乙酰-L-半胱氨酸(NAC)预处理可显著消除冬凌草甲素对RARα的稳定作用。更有趣的是,直接暴露于低浓度的过氧化氢也会增加RARα蛋白水平,但不会增加mRNA水平,这表明ROS在冬凌草甲素稳定RARα蛋白中发挥作用。进一步研究表明,NAC拮抗冬凌草甲素诱导的NF-κB信号激活,而NF-κB信号抑制剂Bay 11-7082有效阻断冬凌草甲素引起的RARα蛋白水平升高。与此一致,IκBα的超抑制形式IκBα(A32/36)的过表达或NF-κB-p65敲低可抑制冬凌草甲素或过氧化氢诱导的RARα稳定性。最后,肿瘤坏死因子α(TNFα)作为NF-κB信号的经典激活剂,调节RARα蛋白的稳定性。
冬凌草甲素通过增加细胞ROS水平来稳定RARα蛋白,这会导致NF-κB信号通路的激活。